(S (NP (DT The) (JJ pharmaceutical) (NN industry)) (VP (VBZ is) (VP (VBN plagued) (PP (IN by) (NP (NP (DT the) (NN problem)) (PP (IN of) (NP (NP (NN side) (NNS effects)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB occur) (NP (NP (RB anytime)) (SBAR (S (NP (DT a) (JJ prescribed) (NN medication)) (VP (VBZ is) (VP (VBN ingested)))))))))))))))) (. .))
(S (NP (EX There)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT a) (JJ recent) (NN interest)) (PP (IN in) (S (VP (VBG using) (NP (NP (DT the) (JJ vast) (NNS quantities)) (PP (IN of) (NP (JJ medical) (NNS data))) (ADJP (JJ available) (PP (IN in) (NP (JJ longitudinal) (JJ observational) (NNS databases))))) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ causal) (NNS relationships)) (PP (IN between) (NP (NP (NNS drugs)) (CC and) (NP (JJ medical) (NNS events)))))))))))))) (. .))
(S (ADVP (RB Unfortunately)) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (VBG existing) (NN post) (NN marketing) (NN surveillance) (NN algorithms)))) (VP (NN measure) (SBAR (WHADJP (WRB how) (NN dependant) (CC or) (VBN associated)) (S (NP (DT an) (NN event)) (VP (VBZ is) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (NN drug)))))))) (PP (RB rather) (IN than) (S (VP (VBG measuring) (NP (NN causality)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP investigate) (NP (NP (JJ potential) (NNS attributes)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (JJ causal) (NN inference))) (S (VP (TO to) (VP (VB identify) (NP (NN side) (NNS effects)) (PP (VBN based) (PP (IN on) (NP (DT the) (NNP Bradford-Hill) (NN causality) (NNS criteria)))))))))))))) (. .))
(S (S (NP (JJ Potential) (NNS attributes)) (VP (VBP are) (VP (VBN developed) (PP (IN by) (S (VP (VBG considering) (NP (NP (CD five)) (PP (IN of) (NP (DT the) (NN causality) (NNS criteria)))))))))) (CC and) (S (NP (NN feature) (NN selection)) (VP (VBZ is) (VP (VBN applied) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (ADJP (RBS most) (JJ suitable))) (PP (IN of) (NP (DT these) (NNS attributes))) (PP (IN for) (S (VP (VBG detecting) (NP (JJ side) (NNS effects)))))))))))) (. .))
(S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NNS attributes)) (VP (VBN based) (PP (IN on) (NP (DT the) (NN specificity) (NN criterion))))) (VP (MD may) (VP (VB improve) (NP (NN side) (NN effect) (VBG signalling) (NNS algorithms)))))))) (CC but) (S (NP (NP (DT the) (NN experiment) (CC and) (NN dosage) (NNS criteria) (VBZ attributes)) (VP (VBN investigated) (PP (IN in) (NP (DT this) (NN paper))))) (VP (VBD did) (RB not) (VP (VB offer) (NP (JJ sufficient) (JJ additional) (NN information))))) (. .))
